首页> 外国专利> COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, COMPRISING LACTIC ACID BACTERIA-DERIVED EXTRACELLULAR VESICLES AS ACTIVE INGREDIENTS

COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, COMPRISING LACTIC ACID BACTERIA-DERIVED EXTRACELLULAR VESICLES AS ACTIVE INGREDIENTS

机译:用于预防或治疗炎症性疾病的组合物,其包含乳酸菌来源的细胞外囊泡作为活性成分

摘要

The present invention relates to: a composition for preventing, ameliorating, or treating inflammatory diseases, the composition comprising, as active ingredients, lactic acid bacteria-derived extracellular vesicles isolated from culture fluid of lactic acid bacteria; and a method for diagnosing atopic dermatitis. It was confirmed via in vitro and in vivo experiments that the lactic acid bacteria-derived extracellular vesicles according to the present invention are significantly more distributed in the urine and blood of a patient with inflammatory diseases than a normal person, and inflammatory response in epithelial cells and inflammatory cells caused by exposure to Staphylococcus or Pseudomonas- derived extracellular vesicles is efficiently inhibited by the lactic acid bacteria-derived extracellular vesicles. Thus, the composition comprising the lactic acid bacteria-derived extracellular vesicles as active ingredients is expected to be usefully used in development of drugs, cosmetics, or health functional food for preventing, ameliorating, or treating inflammatory diseases such as atopic dermatitis, chronic rhinitis, chronic rhinosinusitis, asthma, chronic obstructive pulmonary disease, sepsis, etc. Also, the composition will be usefully used for diagnosis of atopic dermatitis by measuring the distribution of lactic acid bacteria-derived extracellular vesicles in a urine or blood sample.
机译:本发明涉及一种用于预防,改善或治疗炎性疾病的组合物,该组合物包含作为活性成分的,从乳酸菌的培养液中分离的乳酸菌来源的细胞外囊泡。和诊断特应性皮炎的方法。通过体外和体内实验证实,根据本发明的乳酸菌来源的细胞外囊泡在患有炎症性疾病的患者的尿液和血液中比正常人明显更多地分布,并且炎症反应在上皮细胞中乳酸菌来源的细胞外泡可有效抑制因暴露于葡萄球菌或假单胞菌来源的细胞外泡而引起的炎症细胞。因此,预期包含源自乳酸菌的细胞外囊泡作为活性成分的组合物可有效地用于开发药物,化妆品或保健功能食品,以预防,改善或治疗炎性疾病,例如特应性皮炎,慢性鼻炎,慢性鼻-鼻窦炎,哮喘,慢性阻塞性肺疾病,败血症等。此外,该组合物通过测量尿液或血液样品中乳酸菌来源的细胞外囊泡的分布,可用于诊断特应性皮炎。

著录项

  • 公开/公告号EP3269378B1

    专利类型

  • 公开/公告日2020-08-05

    原文格式PDF

  • 申请/专利权人 MD HEALTHCARE INC.;

    申请/专利号EP20160762026

  • 申请日2016-03-11

  • 分类号A61K35/747;A61P11;A61P29;A61P17;A61P11/06;A61P11/02;A61K35/744;G01N33/50;

  • 国家 EP

  • 入库时间 2022-08-21 11:42:17

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号